WHO WE ARE

Mission

Our mission is to promote, advance, and disseminate information and knowledge related to personalizing or individualizing medicine. Our organization provides a platform of convergence, where healthcare stakeholders, including patients and families, providers, payors, academic institutions, pharmacies, genetic laboratories and other groups or individuals, would engage, share data, contribute and co-develop insights that could be used for developing solutions that would enable recommending the right treatment or drug or care for the right patient at the right time.

About Precision Medicine

Precision medicine is an approach to disease treatment and prevention that seeks to maximize effectiveness by considering individual variability in genes, environment, and lifestyle. Precision medicine seeks to redefine our understanding of disease onset and progression, treatment response, and health outcomes through the more precise measurement of molecular, environmental, and behavioral factors that contribute to health and disease.[1]

[1] https://www.nih.gov/sites/default/files/research-training/initiatives/pmi/pmi-working-group-report-20150917-2.pdf

Precision Medicine Initiative

“Doctors have always recognized that every patient is unique, and doctors have always tried to tailor their treatments as best they can to individuals. You can match a blood transfusion to a blood type — that was an important discovery. What if matching a cancer cure to our genetic code was just as easy, just as standard? What if figuring out the right dose of medicine was as simple as taking our temperature?”

– President Obama, January 30, 2015

 

Precision Medicine Initiative is comprised of many components, incorporating efforts from across the government, including the Food and Drug Administration’s (FDA’s) effort to develop a nimble framework for the regulation of genomic technologies; the Office of the National Coordinator for Health Information Technology’s (ONC’s) work to identify data standards critical for precision medicine; the Department of Veterans Affairs (VA) commitment to the Million Veteran Program (MVP); and efforts from the Department of Defense (DoD) to bring active duty women and men into PMI research.

Our Team

 

Executive Director

Anantha Santhanam, Ph.D., M.B.A.

Anantha holds a PhD in Pharmacology, and recently completed his MBA at the Carlson School of Management, University of Minnesota. Prior to joining Apri Health as a Strategic Lead and Head of Operations, Anantha was a Research Scientist and Assistant Professor at the Department of Anesthesiology, Mayo Clinic. He has published over 50 peer-reviewed original scientific articles in the field of cardio- and cerebral vascular disorders, including Stroke and Alzheimer’s Disease. Anantha specializes in healthcare and medical industry innovation, and some of his current engagements cover digital health interventions for cardiac rehabilitation, novel device for gait rehabilitation and data assisted medicine.

“Our healthcare is moving from an “one size fits all approach” to an individualized approach in healthcare delivery, whereby we factor a patient’s genetic, phenotypic and social characteristics in making clinical decisions. However, we realized that currently, these data sets are in disparate silos and do not communicate with each other. To address this fundamental problem, and to help bring the different stakeholders to develop an evidence-based practice of healthcare, we have started Foundation of Precision Medicine. We are putting together a team of committed, talented and successful professionals in different areas of expertise in healthcare. By bringing together experts with complementary skillsets in one place, we are creating an ecosystem where personalized therapies are developed in collaboration to help our patients.”

 

Ayin Vala, M.S.

 

Ayin is a Senior Data Scientist at Apri Health. He studied at Harvard University and his focus has been in Machine Learning and Predictive Analytics. He enjoys working with data to tackle the not so efficient health care system to improve people’s lives. His favorite project is the work with Alzheimer’s patient’s data to figure out which population would benefit from a medicine, which is part of our Precision Medicine efforts, and to predict which patients are likely to have dementia. He is currently working on an exciting deep learning model to do this and looking forward to the results.

“Every day we see examples of the impact of machine learning and artificial intelligence in transportation, information technology, finance, and other sectors.   However, the transformative impact has not been realized in medicine and especially personalized medicine. Computing has become very powerful and analytics algorithms have become smart enough to spot patterns in patient characteristics and treatments to provide discovery.  Complex disease processes like Alzheimer’s Disease cannot be cured by pharmaceutical or genetic sciences alone and current treatments and therapies lead to mixed successes.  By introducing more data-driven investigation we can consider individual variability in medicine intake, lifestyle, and genetic factors for each person and use the power of big data and artificial intelligence to treat challenging diseases.”

 

 

Mark Ereth, M.D.

Mark H. Ereth, MD is an Emeritus Professor of Anesthesiology at Mayo Clinic College of Medicine.  Dr. Ereth recently retired from a clinical practice spanning over 25 years at Mayo where he provided anesthetic and intensive care to over 10,000 patients. Dr. Ereth’s sub-specialty is Cardiovascular and Thoracic Anesthesiology and he worked daily with some of the world’s best surgeons doing some of the world’s most complex procedures.  Recently he founded and serves as CEO of Apri Health, a healthcare data and analytics firm.

Dr. Ereth also co-founded and serves as Chair Emeritus of Cheetah Development. This non-profit organization uses a novel model of aid (Micro-Venture Capital) to find, fund, and mentor entrepreneurs in Tanzania. This unique organization is helping create whole new economies and enhances the financial, water, and health care aspects of numerous rural villages.

“The National Science Foundation recognizes that advances in healthcare will not only come from the laboratory but also from using computer machine learning and artificial intelligence.  We at the Foundation for Precision Medicine are honored to partner with the National Science Foundation to help define the future of hyper-personalized healthcare.  By leveraging machine learning and artificial intelligence coupled with our extensive data sets the Foundation for Precision Medicine will discover and define new ways of caring for patients and their families.” 

Robert Tabz

Robert Tabz is the co-founder of Jougert bar and has been in his role as president since its opening in February 2014. Prior to founding Jougert bar, Robert worked in software sales at Oracle. He holds a B.A. in Globalization and Sociology of Marketing. He is fluent in four languages.

After losing his mother to Alzheimer’s, Robert Tabz promised her that he would dedicate his time in helping find a cure for Alzheimer’s. He has put together a world class team of scientists, medical doctors, and philanthropists, to make the Foundation for Precision Medicine possible. He is an active board member who is in touch with our team of Scientists on a weekly basis. Vincent Cusimano and Robert Tabz have pledged a portion of all transactions at Jougert bar to go towards the Foundation for precision medicine.

One of his favorite Alzheimer’s quotes
“If you learn to listen for
clues as to how I feel
instead of what I say,
you will be able to
understand me
much better”

 

Manuel Fontes, M.D.

Manuel L. Fontes, MD, is Professor of Anesthesiology and Critical Care Medicine at Yale University School of Medicine. He is the Division Chief for Cardiac Anesthesia and the Director of Clinical Research for the Department of Anesthesiology at Yale.

Dr. Fontes earned his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts. He completed his residency in anesthesiology and a fellowship in cardiothoracic anesthesiology at the New York–Presbyterian Hospital/Cornell University Medical Center. Dr. Fontes followed this with 2 years as a postdoctoral fellow and clinical instructor in the Department of Anesthesiology at the University of California, San Francisco, School of Medicine.

Dr. Fontes was named Physician of the Year for 2005 and 2006 and America’s Top Anesthesiologist for 2007-2014. He is a member of several professional organizations, such as the American Society of Anesthesiologists, the Society of Critical Care Medicine, and the American Society of Critical Care Anesthesiologists. Dr. Fontes serves as a reviewer for medical journals, including Critical Care Medicine, Current Opinion in Anesthesiology, and the Journal of Clinical Anesthesia. He is an Associated Editor for the renown Textbook; Anesthesiology, Problem Oriented Patient Management He also maintains an active research program focusing on cardiovascular issues, and he has authored or coauthored more than 150 original articles, reviews, and abstracts.

He is very active in Global Health through involvement in medical missions around the World

Jamison Feramisco, M.D., Ph.D.

Dr. Feramisco received his MD and PhD from the University of Texas Southwestern where he completed work on cholesterol metabolism in the lab of Nobel laureates Drs. Mike Brown and Joseph Goldstein.  He completed residency training in Internal Medicine and Dermatology at the University of California San Francisco.  Jamison is a Silicon Valley physician having been involved in numerous healthcare technology startups…mostly focused around deep data and analytics.  He and his wife Haunah and daughter Fiona reside in Dallas.

Jamison is most passionate about discovery and actionable analytics.  He directs the interrogation of gigantic data sets that lead to the derivation of clinical algorithms and analytic tools. A futurist and visionary he sees the next wave of healthcare discovery not coming from the laboratory but from and through data sciences.

 

Board of Directors

Advisory Board

Ayin Vala, M.S., M.A.

Anantha Santhanam, Ph.D., M.B.A.

Mark Ereth, M.D.

Karen Hastings Ereth, B.S.

Jamison Feramisco, M.D.

Robert Tabz, B.S.

Manuel L. Fontes, M.D.

Gregory A. Poland, M.D., Mayo Clinic Rochester

Ronald Petersen, M.D., Mayo Clinic Alzheimer’s Disease Research Center

Ajay Kumar, M.D., Chief, Department of Medicine, Hartford Health

Others, to be announced

Academic Partners

Yale University

School of Medicine

Mayo Clinic

College of Medicine

Johns Hopkins

School of Medicine

Hartford Health

Kurashiki Central Hospital

Kurashiki, Japan

Industry Partners

CQentia

SecureAire, Inc.

ApriHealth, Inc.